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Background: Individuals with schizophrenia spectrum diagnoses have deficient visual
information processing as assessed by a variety of paradigms including visual backward
masking, motion perception and visual contrast sensitivity (VCS). In the present study,
the VCS paradigm was used to investigate potential differences in magnocellular (M)
vs. parvocellular (P) channel function that might account for the observed information
processing deficits of schizophrenia spectrum patients. Specifically, VCS for near threshold
luminance (black/white) stimuli is known to be governed primarily by the M channel, while
VCS for near threshold chromatic (red/green) stimuli is governed by the P channel.
Methods: VCS for luminance and chromatic stimuli (counterphase-reversing sinusoidal
gratings, 1.22 c/degree, 8.3Hz) was assessed in 53 patients with schizophrenia (including
5 off antipsychotic medication), 22 individuals diagnosed with schizotypal personality
disorder and 53 healthy comparison subjects.
Results: Schizophrenia spectrum groups demonstrated reduced VCS in both conditions
relative to normals, and there was no significant group by condition interaction effect.
Post-hoc analyses suggest that it was the patients with schizophrenia on antipsychotic
medication as well as SPD participants who accounted for the deficits in the luminance
condition.
Conclusions: These results demonstrate visual information processing deficits in
schizophrenia spectrum populations but do not support the notion of selective
abnormalities in the function of subcortical channels as suggested by previous studies.
Further work is needed in a longitudinal design to further assess VCS as a vulnerability
marker for psychosis as well as the effect of antipsychotic agents on performance in
schizophrenia spectrum populations.
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INTRODUCTION
Patients with schizophrenia (SZ), their first degree relatives
and individuals diagnosed with schizotypal personality disorder
(SPD) have deficient visual information processing as assessed
by a variety of paradigms including visual backward mask-
ing (VBM), motion perception, spatial localization, eye track-
ing and visual contrast sensitivity (VCS) (Braff and Saccuzzo,
1981; Schwartz and Winstead, 1985; Schwartz et al., 1987, 1988;
Green et al., 1994; O’Donnell et al., 1996; Saccuzzo et al., 1996;
Cadenhead et al., 1998; Slaghuis, 1998; Chen et al., 1999; Green
and Nuechterlein, 1999; Slaghuis and Curran, 1999; Keri et al.,
2000, 2002; Butler et al., 2001). With increasing knowledge of
information processing in the visual system, it has been possible
to apply newer paradigms in SZ spectrum populations in order to
specify the underlyingmechanisms and possible neural substrates
responsible for the observed deficits.
Physiological and anatomical data have documented the exis-
tence of two major subcortical pathways that originate in the
eye and project to primary visual cortex, the magnocellular (M)
and parvocellular (P) pathways (Breitmeyer and Ganz, 1976;
Lennie, 1980; Kaplan and Shapley, 1986; Livingstone and Hubel,
1987; Bassi and Lehmkuhle, 1990). The M pathway is sensi-
tive to low spatial frequency patterns, high temporal frequen-
cies, and exhibits transient (on/off) responses to visual stimuli
(Breitmeyer and Ganz, 1976; Lennie, 1980; Kaplan and Shapley,
1986; Livingstone and Hubel, 1987; Bassi and Lehmkuhle, 1990).
By contrast, the P pathway is sensitive to high spatial fre-
quency patterns, low temporal frequencies, and shows sustained
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responses to stimuli (Breitmeyer and Ganz, 1976; Lennie, 1980;
Kaplan and Shapley, 1986; Livingstone and Hubel, 1987; Bassi
and Lehmkuhle, 1990). Most relevant to the current study,
the M pathway exhibits high contrast sensitivity to luminance
(light/dark) patterns, and low contrast sensitivity to chromatic
(red/green) patterns; conversely, the P pathway exhibits high
contrast sensitivity to chromatic (red/green) patterns and low
contrast sensitivity to luminance (light/dark) patterns (Lee et al.,
1990; Shapley, 1990; Smith et al., 1995; Dobkins et al., 2009). In
terms of cortical projections, the M pathway provides input to
both the dorsal processing stream (the “where” system, which
processes motion and space information) and the ventral pro-
cessing stream (the “what” system, which processes object infor-
mation) (Maunsell et al., 1990; Thiele et al., 2001), while the
P pathway provides input primarily to the ventral processing
stream.
To investigate the integrity of theM and P pathways in SZ, vari-
ous psychophysical and neurophysiological approaches have been
used that tap into the known visual properties of the two, or tap
into the dorsal/ventral pathways that receive asymmetrical input
from the M and P subcortical pathways (see above). In an early
visual information processing study in SZ patients, Schwartz and
Winstead (1982) assessed visible persistence by sequentially pre-
senting sine-wave gratings of varying spatial frequencies, in order
to differentially stimulate the parallel visual pathways. Both acute
and chronic patients with SZ required longer inter-stimulus inter-
vals (ISI’s) than controls, with chronic patients performing most
poorly when exposed to low spatial frequency stimuli that were
utilized to bias activity in the magnocellular pathway. These find-
ings were interpreted as either abnormal visual pathway (mainly
M pathway) activity or a dysfunction in inhibitory mechanisms
between the pathways that prevented the termination of visible
persistence (Schwartz and Winstead, 1982).
Visual Backward Masking (VBM) paradigms have been devel-
oped that use different spatial frequency masks or require par-
ticipants to locate (dorsal stream function) or identify (ventral
stream function) target stimuli (Balogh and Merritt, 1987; Green
et al., 1994; Cadenhead et al., 1998; Slaghuis and Curran, 1999).
In the VBM paradigm, patients with SZ have been shown to
exhibit deficits in the location, but not the identification, task
when compared to normal comparison participants (Green et al.,
1994; Cadenhead et al., 1998). Because locating targets in space
is thought to be a dorsal stream function, and because the dorsal
stream receives primarily M pathway input, this result has been
interpreted as evidence of abnormal M pathway (subcortical) or
dorsal stream (cortical) processing in SZ. As noted, there is con-
siderable overlap between the M and P visual channels as early
as the primary visual cortex (V1) and this interaction extends
into the dorsal and ventral streams occurring thereafter (Kovacs
et al., 1995; Sawatari and Callaway, 1996; Keri et al., 2000; Butler
et al., 2007; Skottun and Skoyles, 2007) making it difficult to con-
clude from the VBM paradigm alone whether there are specific
subcortical pathway deficits.
Perhaps one of the most straightforward ways in whichM vs. P
pathway processing in SZ has been investigated has been to mea-
sure VCS to stimuli designed to activate one pathway more than
the other (Schwartz and Winstead, 1985, 1997; Schwartz et al.,
1987, 1988; Slaghuis, 1998; Chen et al., 1999; Keri et al., 2000,
2002; Butler et al., 2001, 2009; Kiss et al., 2010; Kent et al., 2011;
Halasz et al., 2013). VCS is defined as the inverse of the contrast
needed in a stimulus (typically, a sinusoidal grating) in order for
that stimulus to be just barely detectable, referred to as “contrast
threshold.” The advantage of using the VCS paradigm is that it can
isolate activity in a given pathway. The logic behind this approach
is based on the fact that most stimuli will stimulate neurons in
both the M and P pathways, for example, a high temporal fre-
quency stimulus will activate both M and P neurons. However,
given that one pathway is more sensitive to that stimulus (e.g.,
M neurons are more sensitive to high temporal frequency than
are P neurons), one can assume that—at contrast threshold, only
the more sensitive pathway (in this example, the M pathway) is
responding to the stimulus (Smith and Edgar, 1991; Dobkins and
Albright, 1995).
Using this approach, previous studies have measured VCS
to different spatial/temporal frequencies, designed to isolate the
M vs. P pathways. Slaghuis (1998; Slaghuis and Curran, 1999)
examined VCS for stationary and moving stimuli across a range
of spatial frequencies and reported that SZ patients with pre-
dominantly positive symptoms exhibited deficits at medium
and high spatial frequencies, suggesting P pathway dysfunction,
while the patients with predominantly negative symptoms per-
formed poorly at all spatial frequencies, suggesting both M and
P pathway dysfunction. Kéri and colleagues (2002) showed that
patients with SZ have reduced VCS in the medium to high
spatial frequency range in a stationary condition and over the
full spatial frequency range in a moving condition. While the
VCS dysfunction did not appear to be specific to either the
M or P channel in the Kéri et al. study, more severe VCS
deficits were associated with antipsychotic dose and Simpson
Angus ratings of extrapyramidal side effects. Chen and col-
leagues (1999, 2003) did not find VCS deficits in SZ patients
tested at low spatial frequency and varying temporal frequen-
cies but reported that unmedicated patients (N = 6) exhib-
ited VCS that was greater than that of normal participants.
Furthermore, those patients on atypical antipsychotics were
unimpaired while patients on typical antipsychotics had lower
VCS. More recently, Kiss et al. (2010) have also reported that
never medicated first episode patients with SZ (N = 20) have
greater VCS in a pedestal condition that emphasizes M chan-
nel activity. The finding of reduced VCS in patients with SZ
on antipsychotics in the Kéri and Chen et al. studies is simi-
lar to observations of reduced VCS in patients with Parkinson’s
Disease, suggesting that some of the effect may be secondary to
modulation of spatiotemporal VCS functions by a hypodopamin-
ergic state (Bulens et al., 1986, 1987, 1989; Bodis-Wollner et al.,
1987). O’Donnell et al. (2006), however, found that both medi-
cated and unmedicated patients with SZ were impaired relative
to normals across both high and low spatial frequencies. In
the same study, individuals meeting the DSM-IV criteria for
SPD did not differ from normals. Similarly, Kent et al. (2011)
reported that SPD patients had VCS deficits at low temporal
frequencies. Using a visual evoked potential paradigm, Butler
and colleagues (Butler et al., 2001, 2009) examined near thresh-
old luminance and chromatic contrast (to emphasize M or P
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visual pathway activity, respectively) in patients with SZ in two
studies who showed lower response levels to stimuli that were
M biased (low luminance contrast with large squares) while
P biased stimuli (low chromatic contrast) did not differenti-
ate them from normals. All but 2 of the participants in the
Butler et al. study were receiving antipsychotic medications at
the time of testing; therefore, a medication effect could not be
excluded.
In summary, it is not clear from the current literature whether
the observed visual information processing deficits in SZ spec-
trum patients are specific to M vs. P visual channel dysfunction.
An important finding that has emerged is that dopaminemodula-
tion via D2 receptor blockade likely affects VCS in SZ patients and
may account for the observed deficits across a range of paradigms.
In the current study, we likewise capitalized on M and P path-
way differences in luminance and chromatic contrast sensitivities,
respectively. To this end, VCS was measured in patients with SZ
and individuals meeting criteria for SPD. The SPD participants
are important because they do not have many of the confound-
ing variables such as acute psychosis or medication effects seen
in a chronic SZ population yet represent a SZ spectrum phe-
notype. It was predicted that patients diagnosed with SZ and
individuals meeting the criteria for SPD would have lower con-
trast sensitivities consistent with other studies but we wanted to
determine whether these differences were specific to either visual
channel. Finally, to better understand the relationship of antipsy-
chotic medication to VCS, the effect of antipsychotic medication
were examined separately in post-hoc analyses.
MATERIALS AND METHODS
PARTICIPANTS
Participants included 53 (40M/13F) patients with SZ, 22
(11M/11F) individuals who met criteria for SPD and 53
(30M/23F) healthy comparison (HC) subjects. Participants pro-
vided written informed consent after receiving an explanation of
the study. Individuals with a history of major medical or neu-
rological disorders or significant drug abuse in the past were
excluded. Additionally, all participants were screened for current
drug use using urine toxicology tests. HC subjects were recruited
through newspaper advertisements and had no history of Axis I
or II disorders as assessed by the Structured Clinical Interview for
DSM-IV Disorders (SCID I and SCID II) nor any family history
of SZ in a first or second degree relative by self report. Established
inter-rater reliability for the SCID in our laboratory is 0.98 (Perry
and Braff, 1998).
SZ patients were recruited through inpatient and outpatient
facilities at UCSD, a long term care facility, and the San Diego
Alliance for the Mentally Ill. All participants received the SCID to
confirm the diagnosis of SZ. Five SZ patients were not receiving
antipsychotic agents.
SPD participants were recruited from outpatient facilities at
UCSD and by newspaper advertisements per our established
methods (Cadenhead et al., 2000). Additional SPD participants
were identified through screening of potential normal compar-
ison participants. All SPD participants were assessed with the
SCID I and the Structured Interview for DSM-IV Personality
Disorders (SIDP) by one of the investigators (KSC) to identify the
diagnosis of SPD. Two SPD participants were receiving a low dose
typical antipsychotic (perphenazine 6Mg qd or trifluoperazine
2mg).
All participants were screened for color blindness using
Ishihara’s tests for color deficiency (Ishihara, 1986) and were
reported to have corrected visual acuity of 20/50 or better as
measured by the Snellen Eye Chart.
VISUAL CONTRAST SENSITIVITY
Apparatus and stimuli
Stimuli were generated using a Power Macintosh 8100/80 PC
computer and Nanao T2-17TS FlexScan Color Monitor (1152 ×
870 pixels, 75Hz). The 8-bit video board allowed for 256 dis-
crete levels of luminance. The CIE coordinates for the monitor
primaries were: Red (0.61, 0.342), Green (0.298, 0.588), and
Blue (0.151, 0.064). The maximum output for the monitor was
calibrated to equal energy white (CIE chromaticity coordinates
= 0. 333, 0.333), and the voltage/luminance relationship was lin-
earized independently for each of the three guns in the display,
using a PR-650 Colorimeter (Photoresearch). The PR-650 was
used for photometric measurements to standardize to Vλ iso-
luminance, as well as for spectroradiometric measurements to
compute L and M cone modulations produced by our visual
stimuli.
Stimuli were 1.22 cycles/degree horizontally-oriented sinu-
soidal gratings moving at a temporal frequency 8.33Hz and are
either luminance (light/dark) or chromatic (red/green). Each trial
consisted of a luminance or chromatic stimulus, subtending a
visual angle of 1.64 degrees (a total of 2 cycles), centered 2.28
degree to the left or right of a fixation cross in screen center, for a
duration of 120Ms. Motion was produced by phase-shifting sinu-
soidal gratings at regular intervals in sync with the vertical refresh
of the video monitor (75Hz).
Luminance (light/dark) gratings. Luminance-defined gratings
were produced by sinusoidally modulating the red and green
phosphors in phase (with a small amount of blue gun also added
in phase to match the mean chromaticity of the chromatic grat-
ings). For luminance stimuli, r.m.s. (root mean square) cone
contrast values directly correspond to the conventionalMichelson
contrast: [(Lmax − Lmin)/(Lmax + Lmin)], and cone contrasts up to
100% are readily produced. Although the calibration techniques
allow for a specified amount of contrast, the actual luminance
contrast of all stimuli was verified using the PR-650 Colorimeter.
Chromatic (red/green) gratings. Chromatic red/green gratings
were produced by sinusoidally modulating the red and green
phosphors 180 degrees out of phase, with a small amount of blue
primary added in phase with the red portion of the grating so as to
prevent modulation of the short-wavelength-sensitive (S) cones
(Dobkins and Teller, 1996). The cone contrast of these stimuli was
determined by spectroradiometry (with the PR-650) as described
in detail previously (Gunther and Dobkins, 2002).
The red/green isoluminance point for each participant was
determined using a 20 trial task during which participants were
asked to adjust (increase or decrease) the luminance contrast
(interval step = 0.5%) in a moving red/green grating (r.m.s. cone
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contrast = 7.2%) to the point where the pattern was no longer
salient (not visible, faded, jagged or blurry). The mean isolumi-
nance point was used in the chromatic portion of the contrast
sensitivity paradigm (below).
Psychophysical paradigm
The VCS paradigm consisted of a standard 2-alternative-forced-
choice task with feedback. Participants sat in a comfortable chair
and rest their head in a chin rest. They were asked to fix-
ate on a small “+” symbol in the center of a monitor 57 cm
away. The participant started each trial with a key press on
the standard computer keyboard, after which a grating stimu-
lus (luminance or chromatic) of varying contrast appeared on
the left or right side of the display. After the stimulus dis-
appeared, the participant reported its location (left or right)
using color-coded keys. Using a method of constant stimuli
paradigm, six different levels of contrast were presented for
each condition, presented randomly across trials. Participants
were given 100 practice trials to familiarize them with the
task. The experimental session contained 360 trials (180 tri-
als for each the luminance and chromatic conditions) and
lasted approximately 45Min. The experiment was self-paced
and participants were encouraged to take breaks as often as
needed.
Data analysis
Contrast sensitivities. Psychometric curves were fit to data using
Weibull functions and maximum likelihood analysis (Weibull,
1958; Watson, 1979). Contrast threshold was defined as the con-
trast yielding 75% correct performance. In extreme cases where
the performance of a subject was poor in both the luminance
and chromatic conditions so that no threshold could be deter-
mined from the Weibull, the subject was excluded (1 SPD and 7
SZ). All thresholds were analyzed in terms of r.m.s. cone contrast.
Contrast sensitivity was determined from the inverse of thresh-
old (i.e., sensitivity = 1/threshold). Raw contrast sensitivity data
was log10 transformed, because log but not linear sensitivities
conform to normal distributions. Data were analyzed in Two-
Way ANOVAs that included the stimulus type (luminance and
chromatic) and participant group.
RESULTS
DEMOGRAPHICS
Table 1 presents the demographic data of subjects included in
the analysis. The groups did not differ in age [F(2, 127) = 1.8, ns]
or ratio of males to females (Pearson Chi Square Value =
5.3, ns) but education differed between the groups [F(2, 119) =
22.4, p < 0.001] with SZ patients having significantly fewer years
of completed education compared to SPD and HC participants
(both p < 0.001). As expected, SZ patients had poorer func-
tioning (GAF: t = 3.9, p < 0.001) and more symptoms (SANS:
t = 4.9, p < 0.001; SAPS: t = 2.8, p < 0.001) relative to SPD
subjects.
GROUPMEAN CONTRAST SENSITIVITY
The results of a Two-Way ANOVA revealed a significant main
effect of participant group [F(2, 118) = 8.81, p < 0.001]. Post-hoc
Table 1 | Demographics and visual contrast sensitivities.
HC (N = 53) SPD (N = 21) SZ (N = 46)
Age (SD) 33.8 (9.2) 37.8 (9.3) 35.7 (11.3)
Education (SD) 15.2 (2.2) 14.3 (2.6) 11.9 (2.7)
Gender (% male) 56.6 52.4 76.1
GAF (SD) 58.2 (14.9) 43.2 (14.1)
Global SAPS (SD) 6.0 (2.7) 8.8 (5.0)
Global SANS (SD) 4.7 (3.5) 10.9 (5.1)
GAF, global assessment of functioning; SAPS, schedule for the assessment of
positive symptoms; SANS, schedule for the assessment of negative symptoms.
t-tests indicated that this effect was driven by significantly lower
contrast sensitivity (collapsed across luminance and chromatic)
in both SZ spectrum groups as compared to HC subjects (p <
0.05 vs. SPD and p < 0.001 vs. SZ). The SZ and SPD partici-
pants did not significantly differ from each other. There was no
interaction between participant group and stimulus condition
[F(2, 117) = 0.56, ns], indicating that the group differences did not
differ between luminance and chromatic stimuli. There were no
significant gender or interaction effects with gender, and therefore
groups were collapsed across gender for the analyses presented
below. Visual contrast sensitivity in the luminance but not the
chromatic condition was significantly correlated with age while
neither condition was associated with symptoms or functioning
measures above.
MEDICATION EFFECTS
Because of the potential effects of antipsychotic agents on
visual information processing, we conducted further analyses
in which the 2 SPD participants on antipsychotic medication
were removed from the analysis and the 41 patients with SZ
on antipsychotics (SZ+AP) were compared to 5 patients with
SZ who were not on antipsychotics (SZ-AP), the 53 HC and 18
SPD subjects (see Figures 1, 2). A two-factor ANOVA revealed
a significant effect of group [F(3, 114) = 6.77, p < 0.001], driven
by HC vs. SZ patients on antipsychotics (p < 0.001) and HC
vs. SPD (p < 0.05), and a significant group by condition inter-
action [F(3, 114) = 3.86, p < 0.01]. To investigate this interac-
tion further, we performed separate one-factor ANOVAs for
the luminance and chromatic conditions. Both analyses showed
a significant main effect of group [luminance: F(3, 117) = 7.56,
p < 0.001; chromatic: F(3, 117) = 5.03, p < 0.005], but for dif-
ferent reasons. For the luminance condition, post-hoc t-tests
revealed impaired luminance contrast sensitivity in the SZ
patients on antipsychotics as compared to HC (p < 0.001), yet
higher luminance contrast sensitivity in unmedicated SZ patients
vs. antipsychotic medicated patients with SZ (p < 0.005), and
no significant difference between unmedicated SZ patients and
HC subjects. Inspection of the data reveals that the unmed-
icated SZ patient have greater luminance contrast sensitivity
than HCs (effect size = 0.62) but this analysis was not sig-
nificant (p = 0.16). Power analyses indicate that at least 12
subjects per group would be needed to achieve a statistically
significant result (power 0.80, p < 0.05). For the chromatic
condition, post-hoc tests revealed impaired chromatic contrast
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FIGURE 1 | Visual contrast sensitivity (error bars represent SEM) in
the luminance condition comparing healthy comparison (HC),
schizotypal personality disorder (SPD), and schizophrenia (SZ)
subjects. Data from unmedicated SZ subjects as well as SZ subjects on
antipsychotic (AP) medication are also shown relative to the original
group analysis.
FIGURE 2 | Visual contrast sensitivity (error bars represent SEM) in
the chromatic condition comparing healthy comparison (HC),
schizotypal personality disorder (SPD), and schizophrenia (SZ)
subjects. Data from unmedicated SZ subjects as well as SZ subjects on
an antipsychotic (AP) medication are also shown relative to the original
group analysis.
sensitivity in antipsychotic treated SZ patients as well as unmed-
icated patients with SZ and SPD subjects, as compared to
HC subjects (p < 0.001, p < 0.05, and p < 0.05, respectively)
while the antipsychotic treated vs. unmedicated patients did
not differ from each other. Follow-up correlations between
chlorpromazine equivalents and contrast sensitivities within the
antipsychotic treated sample of patients were not significant.
In summary, patients with SZ on antipsychotic medication
have impaired VCS in both luminance and chromatic condi-
tions and the small group of unmedicated patients had nor-
mal luminance contrast and impaired chromatic contrast. Or
stated differently, if we could remove the effects of medica-
tion in SZ patients, they might as a group show atypically high
luminance contrast sensitivity, yet impaired chromatic contrast
sensitivity.
DISCUSSION
Schizophrenia spectrum groups demonstrated reduced VCS in
both luminance and chromatic conditions relative to healthy
subjects, but the relative sensitivity to luminance vs. chromatic
stimuli did not differ between groups. These results replicate
previous findings of visual information processing deficits in
SZ spectrum populations but do not support the notion of
selective abnormalities in the function of the subcortical M
pathway as suggested by previous studies (Butler et al., 2007).
Instead, the results suggest either abnormalities in both M
and P pathways or a more general visual processing deficit
at some point further downstream in individuals diagnosed
with SZ spectrum illness. The M and P pathways are respon-
sible for relaying specific visual information from the retina,
through the lateral geniculate nucleus of the thalamus, to pri-
mary visual cortex (V1), and elsewhere in the cortex. A contrast
detection deficit may arise from dysfunction at any of these
levels.
As noted by previous investigators (Bodis-Wollner et al., 1982;
Bulens et al., 1986, 1987, 1989; Keri et al., 2002; Chen et al.,
2003), the possibility of medication effects accounting for the
visual information processing deficits cannot be entirely ruled
out. The differences between the SZ patients and the HC subjects
in the luminance VCS condition were no longer present when
the small sample of patients (N = 5) not receiving antipsychotics
were compared to HCs. In fact, in the luminance condition, the
five unmedicated SZ patients had contrast sensitivities greater
than those of the antipsychotic treated patients (p < 0.005) and
HC (p = 0.16, d = 0.62) subjects, consistent with the findings by
Chen and colleagues (2003) in six unmedicated SZ patients and
the twenty unmedicated SZ patients in the Kiss et al. study (2010).
It is possible that the hypodopaminergic effect of the antipsy-
chotics accounted for the original difference between groups
in the luminance condition while a hyperdopaminergic state
may increase contrast sensitivity as observed in the unmedicated
patients with SZ. Interpretation of the current findings in unmed-
icated patients, are limited by the small sample size but add to a
growing literature that suggests evidence of overactive M channel
activity.
It is known that dopamine neurotransmission (specifically,
of the horizontal, amacrine, and interplexiform cells) in the
retina is involved in regulating the strength of lateral inhibition
and center-surround antagonism (Tagliati et al., 1994; Sannita,
1995; Djamgoz et al., 1997). A hyperdopaminergic state may
enhance the center-surround processing which could in turn,
enhance contrast sensitivity. Supporting the role of dopamine-
modulation effects, Bodis-Wollner and colleagues (1982) found
that Parkinson’s disease patients treated with L-dopa and unmed-
icated SZ patients had faster visual evoked potentials than
Parkinson’s patients without L-dopa and SZ patients treated with
typical antipsychotics. Similarly, a study by Harris and colleagues
(1990) showed that after a therapeutic injection of depot antipsy-
chotic, unmedicated patients with SZ (N = 8) had enhanced sen-
sitivity at low (0.5 c/degree), and reduced sensitivity at medium
(2 c/degree) and high (8 c/degree) spatial frequencies.
In contrast to the findings in SZ patients, the SPD participants,
who were not taking antipsychotic medications, had deficits in
both luminance and chromatic conditions supporting the notion
of general visual information processing deficits in SZ spectrum
populations that are not accounted for by medication effects.
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These results differ from the findings of O’Donnell and colleagues
(2006) who reported that individuals with SPD did not differ at
any spatial or temporal frequency from healthy subjects and per-
formed significantly better than individuals with SZ. The results
may be due to methodological differences. O’Donnell and col-
leagues did not have a chromatic condition and had a larger age
range. Consistent with our findings, Kent and colleagues (2011)
did find deficits in SPD at all spatial frequencies but the deficits
were more prominent in a pedestal condition that emphasizes
magnocellular activity. Whether or not SPD subjects have visual
contrast deficits, it remains possible that a hyperdopaminegic
state of unmedicated psychotic patients may be enhancing con-
trast sensitivity while SPD patients, who are characterized by only
mild subsyndromal psychotic-like symptoms, tend to have more
prominent deficit symptoms that may reflect hypodopaminergia
that is accounting for the VCS deficits (Siever and Davis, 2004).
Given the present findings in SPD, it remains possible that
the visual information processing deficits as indexed by VCS
could represent trait markers for SZ spectrum illness. The iden-
tification of trait markers for SZ has implications for genetic
studies as well as early identification of individuals at risk for
SZ (Cadenhead, 2002). If reliable trait markers can be utilized
in conjunction with clinical risk factors in identification of indi-
viduals in the prodromal stage of SZ, it may be possible to
intervene earlier and prevent many of the devastating effects of
a first psychotic break. Further understanding of the underly-
ing neuropathology in the developing brain of individuals in
the early stages of SZ could shed insight into targets for early
intervention.
Methodological differences may play a role in discrepancies
across VCS studies. Different visual contrast studies vary in how
sensitivity is measured (e.g, staircase method, method of constant
stimulus), stimuli (random dots vs. sinusoidal gratings), how the
stimuli are presented (side-by-side or sequentially) and which
spatial and temporal frequencies are in the range for biasing pro-
cessing toward the M vs. P pathways. Further, whereas the present
study used luminance (light/dark) and chromatic (red/green)
stimuli to isolate M and P pathway activity, other studies varied
spatial and temporal frequencies.
Moreover, there is a large variance between studies among
the SZ spectrum participants included. Studies differ in partic-
ipants’ ages (O’Donnell et al., 2006), whether participants are
chronic vs. acute case (Keri and Benedek, 2007), how long they
have been on or off antipsychotics (Chen et al., 2003), and if
positive vs. negative symptoms are analyzed separately (Slaghuis
and Thompson, 2003). Furthermore, growing research has shown
that SZ spectrum patients may vary in their dopamine and other
neurotransmitter levels at different points during their illness
(Uchida and Mamo, 2009). With increasing age, there is also a
decline in D2 receptor binding (Antonini and Leenders, 1993).
All of these factors suggest that chronic SZ coupled with years
of dopamine-blocking antipsychotics may contribute to a greater
hypodopaminergic state.
Clearly, further work is needed using a longitudinal design to
chart the course of visual information processing deficits both
on and off antipsychotic medication over the course of SZ from
prodrome to acute to chronic forms of the illness. The use
of VCS paradigms in combination with functional measures of
brain activity may help to determine the mechanism by which
such deficits occur and lead to better treatments that target
specific information processing deficits without causing further
impairment.
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